Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension
- 1 March 2016
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 310 (5) , F372-F384
Abstract
Renovascular hypertension (RVH) is a common cause of both cardiovascular and renal morbidity and mortality. In renal artery stenosis (RAS), atrophy in the stenotic kidney is associated with an influx of macrophages and other mononuclear cells. We tested the hypothesis that chemokine receptor 2 (CCR2) inhibition would reduce chronic renal injury by reducing macrophage influx in the stenotic kidney of mice with RAS. We employed a well-established murine model of RVH to define the relationship between macrophage infiltration and development of renal atrophy in the stenotic kidney. To determine the role of chemokine ligand 2 (CCL2)/CCR2 signaling in the development of renal atrophy, mice were treated with the CCR2 inhibitor RS-102895 at the time of RAS surgery and followed for 4 wk. Renal tubular epithelial cells expressed CCL2 by 3 days following surgery, a time at which no significant light microscopic alterations, including interstitial inflammation, were identified. Macrophage influx increased with time following surgery. At 4 wk, the development of severe renal atrophy was accompanied by an influx of inducible nitric oxide synthase (iNOS)+ and CD206+ macrophages that coexpressed F4/80, with a modest increase in macrophages coexpressing arginase 1 and F4/80. The CCR2 inhibitor RS-102895 attenuated renal atrophy and significantly reduced the number of dual-stained F4/80+ iNOS+ and F4/80+ CD206+ but not F4/80+ arginase 1+ macrophages. CCR2 inhibition reduces iNOS+ and CD206+ macrophage accumulation that coexpress F4/80 and renal atrophy in experimental renal artery stenosis. CCR2 blockade may provide a novel therapeutic approach to humans with RVH.Keywords
Funding Information
- HHS | National Institutes of Health (NIH) (NIAID R01 AI100911, NHLBI P01 HL85307, F30 DK102232, NIGMS T32 GM 6584, UL1 RR024150, F30 DK102232, NIGMS T32 GM 6584)
This publication has 35 references indexed in Scilit:
- Macrophage M1/M2 Polarization Dynamically Adapts to Changes in Cytokine Microenvironments in Cryptococcus neoformans InfectionmBio, 2013
- Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertensionAmerican Journal of Physiology-Renal Physiology, 2012
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2American Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Characterization of resident and migratory dendritic cells in human lymph nodesJournal of Experimental Medicine, 2012
- Genetic deficiency of Smad3 protects against murine ischemic acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2011
- Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor LigandsImmunity, 2011
- Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlatesNephrology Dialysis Transplantation, 2010
- The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertensionJournal Of Hypertension, 2009
- The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic miceCardiovascular Research, 2009
- The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia–reperfusion injuryKidney International, 2008